To evaluate safety of DC vaccination in combination with AI, to evaluate clinical tumor response, to evaluate treatment induced immune response to p53 end to evaluate duration of tumor and immune responses
18 Years and older (Adult, Senior)
July 9, 2009
May 31, 2012
Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark
† Study has passed its completion date and status has not been verified in more than two years.